Collectively, these findings suggest differential regulatory dynamics of the PINK1–PARK2 pathway in obesity, where PINK1 appears consistently upregulated but less variable across individuals, whereas PARK2 expression more closely mirrors the severity of metabolic dysfunction. This evidence concerns the gene PRKN and obesity disorder.